The Budget provides $10 million for a review in two years of an agreement that expires the year after. The Government is investing more in this review than it has in the Health Technology Assessment Review.
Budget reveals wholesaling arrangements are a future focus
March 25, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Chimeric signals board refresh and shareholder support as lead trial advances
November 30, 2025 - - Australian Biotech -
Pharmac announces 90-day dispensed quantities of HIV medicines
November 27, 2025 - - Latest News -
Landmark report warns Australia’s hospital pharmacy system is at an 'inflection point'
November 27, 2025 - - Latest News -
Australia releases first national estimate of women living with metastatic breast cancer
November 27, 2025 - - Latest News -
Imugene and JW Therapeutics join forces on first-in-class combination for solid tumours
November 27, 2025 - - Australian Biotech -
Algorae Pharmaceuticals secures new supply of chemotherapy for Australia through Dr Reddy’s partnership
November 27, 2025 - - Latest News -
An interview that reminds us of the missing discussion in Australia
November 27, 2025 - - Latest News
